Gankyrin Activates IL-8 to Promote Hepatic Metastasis of Colorectal Cancer
Open Access
- 15 July 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 73 (14), 4548-4558
- https://doi.org/10.1158/0008-5472.can-12-4586
Abstract
Hepatic metastasis is responsible for the majority of colorectal cancer (CRC)-related mortalities. Although Gankyrin (PSMD10) has been implicated in cancer metastasis, its exact role and underlying mechanisms of CRC hepatic metastasis remain largely unknown. Herein, we showed that the expression of Gankyrin was higher in primary CRC with hepatic metastasis compared with CRC without metastasis. RNAi-mediated silencing of Gankyrin expression in highly metastatic human CRC cells impaired their migratory and metastatic capacity in vivo. Genome-wide transcriptome profiling revealed activation of the interleukin (IL)-8 signaling pathway by Gankyrin. Protein levels of IL-8 and cyclin D1 (CCND1), the two important molecules in the IL-8 pathway, were positively correlated with Gankyrin expression in human CRC specimens. Furthermore, genetic deletion of cyclin D1 showed its requirement in Gankyrin-mediated cell migration. Finally, administration of recombinant IL-8 rescued the migratory defect of CRC cells where Gankyrin expression was silenced. Together, our findings highlight the importance of Gankyrin in hepatic metastasis of CRC and point out its candidature as a potential prognostic marker and therapeutic target to improve the clinical management of metastatic CRC. Cancer Res; 73(14); 4548–58. ©2013 AACR.Keywords
Other Versions
This publication has 46 references indexed in Scilit:
- Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in Tumorigenesis and MetastasisBMC Medical Genomics, 2012
- The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signalingCell Research, 2011
- p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathwaysHepatology, 2010
- Epigenetic changes play critical role in age‐associated dysfunctions of the liverAging Cell, 2010
- Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cellsJCI Insight, 2010
- Elimination of C/EBPα through the ubiquitin-proteasome system promotes the development of liver cancer in miceJCI Insight, 2010
- BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcomeBritish Journal of Cancer, 2010
- Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without AutoimmunityJNCI Journal of the National Cancer Institute, 2008
- Dissection of Protein–Protein Interaction and CDK4 Inhibition in the Oncogenic versus Tumor Suppressing Functions of Gankyrin and P16Journal of Molecular Biology, 2007
- Gankyrin: An intriguing name for a novel regulator of p53 and RBCancer Cell, 2005